A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

NCT01939977 ·Status: COMPLETED ·Phase: PHASE4

Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)

NCT00701805 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

NCT03280264 ·Status: COMPLETED ·Phase: PHASE3

Paricalcitol Injection Phase II Trial

NCT00646932 ·Status: COMPLETED ·Phase: PHASE2

Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

NCT00990704 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

NCT04064827 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

NCT00664430 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis

NCT01382212 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

NCT00646035 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

NCT01073462 ·Status: COMPLETED

Intravenous Paricalcitol in Chronic Hemodialysis Patients

NCT03023748 ·Status: UNKNOWN ·Phase: PHASE4

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

NCT00823303 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of a Cincalcet Suppression Test

NCT01103206 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

NCT01134315 ·Status: TERMINATED

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

NCT02859896 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

NCT00977080 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

NCT01341782 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

NCT03123406 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

NCT01020487 ·Status: COMPLETED ·Phase: PHASE3

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

NCT00123461 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

NCT01265992 ·Status: COMPLETED

PTH-independent Effects of Encaleret

NCT05735015 ·Status: COMPLETED ·Phase: PHASE2

Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease

NCT00796679 ·Status: COMPLETED ·Phase: NA

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

NCT05836220 ·Status: COMPLETED ·Phase: PHASE3

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

NCT01273597 ·Status: COMPLETED